Rosiglitazone HCl

Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

302543-62-0

≥ 2 years

>98% (HPLC)

393.89

C18H19N3O3S·HCl

Research use only, not for human use.

PPAR

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

bsm-61582R-Cy5.5 100 µL

Ask

abx974196-01 150 µg

Ask

abx974196-02 300 µg

Ask

NBP1-76526PCP 0.1 mL

Ask

MBS1124077-01 0.5 mg (E-Coli)

Ask

MBS1124077-02 0.05 mg (Baculovirus)

Ask